INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 143 filers reported holding INFINITY PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.80 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $14,000 | +180.0% | 2,780 | +282.9% | 0.00% | +100.0% |
| Q4 2015 | $5,000 | -54.5% | 726 | -48.1% | 0.00% | -50.0% |
| Q3 2015 | $11,000 | -83.8% | 1,400 | -77.7% | 0.00% | -83.3% |
| Q2 2015 | $68,000 | -64.4% | 6,264 | -54.3% | 0.01% | -74.5% |
| Q1 2015 | $191,000 | +516.1% | 13,715 | +633.0% | 0.05% | +370.0% |
| Q4 2014 | $31,000 | +520.0% | 1,871 | +378.5% | 0.01% | +900.0% |
| Q3 2014 | $5,000 | – | 391 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,100,000 | $14,762,000 | 6.34% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,882,805 | $52,107,000 | 1.90% |
| Cheyne Capital Management (UK) LLP | 326,821 | $4,388,000 | 1.56% |
| BB BIOTECH AG | 2,320,737 | $31,144,000 | 1.27% |
| Broadfin Capital, LLC | 854,384 | $11,466,000 | 1.20% |
| HealthCor Management, L.P. | 1,162,200 | $15,597,000 | 0.80% |
| Orbimed Advisors | 4,736,900 | $63,569,000 | 0.66% |
| Rhenman & Partners Asset Management AB | 148,000 | $1,986,000 | 0.58% |
| SOUND ENERGY PARTNERS, INC. | 51,000 | $684,000 | 0.53% |
| Rock Springs Capital Management LP | 210,000 | $2,818,000 | 0.44% |